Literature DB >> 15780640

Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.

P Patwari1, G Gao, J H Lee, A J Grodzinsky, J D Sandy.   

Abstract

OBJECTIVE: To investigate the mechanism of aggrecanolysis in interleukin-1 (IL-1)-treated cartilage tissue by examining the time course of aggrecan cleavages and the tissue and medium content of membrane type 4-matrix metalloproteinases (MT4-MMP) and a disintegrin and metalloproteinase with thrombospondin type I motifs (ADAMTS)4.
METHODS: Articular cartilage explants were harvested from newborn bovine femoropatellar groove. The effects of IL-1 treatment with or without aggrecanase blockade were investigated by Western analysis of aggrecan fragment generation, ADAMTS4 species (p68 and p53), and MT4-MMP, as well as by realtime PCR (polymerase chain reaction) for ADAMTS4 and 5. Aggrecanase was blocked with mannosamine (ManN), an inhibitor of glycosylphosphatidylinositol anchor synthesis, and esculetin (EST), an inhibitor of MMP-1, MMP-3, and MMP-13 gene expression.
RESULTS: IL-1 treatment caused a major increase in MT4-MMP abundance in the tissue and medium. ADAMTS4 (p68) was abundant in fresh cartilage and this was retained in the tissue in untreated cartilage. IL-1 treatment for 6 days caused a marked loss of p68 from the cartilage and the appearance of p53 in the medium. Addition of either 1.35 mM ManN or 31-500 microM EST blocked IL-1-mediated aggrecanolysis and this was accompanied by nearly complete inhibition of the MT4-MMP increase, the p68 loss and the formation of p53. IL-1 treatment increased mRNA abundance for ADAMTS4 ( approximately 3-fold) and ADAMTS5 ( approximately 10-fold) but this was not accompanied by a marked change in enzyme protein abundance.
CONCLUSION: These studies support a central role for MT4-MMP in IL-1-induced cartilage aggrecanolysis and are consistent with the identification of p68 as the aggrecanase that cleaves within the CS2 domain, and of p53 as the aggrecanase that generates G1-NITEGE. Since the induction by IL-1 was not accompanied by marked changes in total ADAMTS4 protein, but rather in partial conversion of p68 to p53 and release of both from the tissue, we conclude that aggrecanolysis in this model system results from MT4-MMP-mediated processing of a resident pool of ADAMTS4 and release of the p68 and p53 from their normal association with the cell surface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780640      PMCID: PMC2771540          DOI: 10.1016/j.joca.2004.10.023

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  49 in total

1.  ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan.

Authors:  K Kuno; Y Okada; H Kawashima; H Nakamura; M Miyasaka; H Ohno; K Matsushima
Journal:  FEBS Lett       Date:  2000-08-04       Impact factor: 4.124

2.  Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity.

Authors:  E C Arner; M A Pratta; J M Trzaskos; C P Decicco; M D Tortorella
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

3.  Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.

Authors:  P Patwari; B Kurz; J D Sandy; A J Grodzinsky
Journal:  Arch Biochem Biophys       Date:  2000-02-01       Impact factor: 4.013

4.  Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid.

Authors:  J D Sandy; V Thompson; C Verscharen; D Gamett
Journal:  Arch Biochem Biophys       Date:  1999-07-15       Impact factor: 4.013

5.  ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.

Authors:  Chris B Little; Laureane Mittaz; Daniele Belluoccio; Fraser M Rogerson; Ian K Campbell; Clare T Meeker; John F Bateman; Melanie A Pritchard; Amanda J Fosang
Journal:  Arthritis Rheum       Date:  2005-05

6.  Esculetin suppresses proteoglycan metabolism by inhibiting the production of matrix metalloproteinases in rabbit chondrocytes.

Authors:  K Watanabe; A Ito; T Sato; T Saito; H Hayashi; Y Niitani
Journal:  Eur J Pharmacol       Date:  1999-04-16       Impact factor: 4.432

7.  Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.

Authors:  Y Wang; A R Johnson; Q Z Ye; R D Dyer
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

8.  Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.

Authors:  V Ganu; R Melton; W Wang; D Roberts
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

9.  Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.

Authors:  J D Sandy; D Gamett; V Thompson; C Verscharen
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

10.  Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.

Authors:  Y Itoh; M Kajita; H Kinoh; H Mori; A Okada; M Seiki
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.486

View more
  31 in total

1.  Response of cartilage and meniscus tissue explants to in vitro compressive overload.

Authors:  J F Nishimuta; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2012-01-13       Impact factor: 6.576

2.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

3.  Cell death-associated ADAMTS4 and versican degradation in vascular tissue.

Authors:  Richard D Kenagy; Seung-Kee Min; Alexander W Clowes; John D Sandy
Journal:  J Histochem Cytochem       Date:  2009-06-08       Impact factor: 2.479

4.  Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis.

Authors:  Kodihalli C Ravindra; Caroline C Ahrens; Yang Wang; Julie Y Ramseier; John S Wishnok; Linda G Griffith; Alan J Grodzinsky; Steven R Tannenbaum
Journal:  J Biol Chem       Date:  2018-05-23       Impact factor: 5.157

5.  Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties.

Authors:  Christopher G Wilson; Ashley W Palmer; Fengrong Zuo; Elsie Eugui; Stacy Wilson; Rebecca Mackenzie; John D Sandy; Marc E Levenston
Journal:  Matrix Biol       Date:  2006-11-11       Impact factor: 11.583

6.  Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase.

Authors:  Anjum Sohail; Marta Marco; Huiren Zhao; Qicun Shi; Scott Merriman; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

7.  Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.

Authors:  M Durigova; L Troeberg; H Nagase; P J Roughley; J S Mort
Journal:  Eur Cell Mater       Date:  2011-01-12       Impact factor: 3.942

8.  10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin.

Authors:  D R McCulloch; J D Wylie; J-M Longpre; R Leduc; S S Apte
Journal:  Osteoarthritis Cartilage       Date:  2009-11-04       Impact factor: 6.576

Review 9.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

10.  In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.

Authors:  David Pretzel; Dirk Pohlers; Sönke Weinert; Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2009-02-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.